Update on Dementia of the Alzheimer Type
Abstract
An estimated three-quarters to one million Americans are in advanced stages of dementia of the Alzheimer type (DAT), numbers that are certain to grow as the population of the United States ages. An explosion in research interest in DAT in the last ten years promises greater understanding of the pathophysiology of the disease and eventual development of effective treatment of characteristic intellectual deficits and behavioral symptoms. The search continues for the underlying cause or causes of the condition and a cure. This article reviews current information about the epidemiology, neuropathologic findings, diagnosis, and treatment of DAT and some of the most promising areas of research.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).